社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
fongms
IP属地：未知
+关注
帖子 · 21
帖子 · 21
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
fongms
fongms
·
2021-12-30
Good
非常抱歉，此主贴已删除
看
1,015
回复
评论
点赞
2
编组 21备份 2
分享
举报
fongms
fongms
·
2021-12-20
Tesla can buy for long term
看
1,274
回复
1
点赞
2
编组 21备份 2
分享
举报
fongms
fongms
·
2021-12-01
Pfizer
Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?
Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks
Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?
看
1,086
回复
2
点赞
6
编组 21备份 2
分享
举报
fongms
fongms
·
2021-11-26
Its good
Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash
Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at
Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash
看
784
回复
1
点赞
6
编组 21备份 2
分享
举报
fongms
fongms
·
2021-11-23
Power
Here's what Powell's nomination for 2nd term as Fed chairman means for markets
Investors buoyed by 'continuity' as rival Brainard gets No. 2 spot, analysts say MarketWatch photo i
Here's what Powell's nomination for 2nd term as Fed chairman means for markets
看
1,274
回复
评论
点赞
2
编组 21备份 2
分享
举报
fongms
fongms
·
2021-11-10
Cool
Why Are PubMatic Shares Trading Higher Premarket?
Oppenheimer analyst Jason Helfstein raised the price target on PubMatic Inc to $50 from $45, implyin
Why Are PubMatic Shares Trading Higher Premarket?
看
1,214
回复
评论
点赞
6
编组 21备份 2
分享
举报
fongms
fongms
·
2021-10-26
Good
非常抱歉，此主贴已删除
看
1,363
回复
评论
点赞
3
编组 21备份 2
分享
举报
fongms
fongms
·
2021-10-08
Its a good start
Vaxart gained 7% in premarket trading
(Oct 8) Vaxart, Inc shares are up 7% in premarket trading after publishing results in an animal mode
Vaxart gained 7% in premarket trading
看
714
回复
评论
点赞
5
编组 21备份 2
分享
举报
fongms
fongms
·
2021-10-07
Good
非常抱歉，此主贴已删除
看
1,225
回复
评论
点赞
2
编组 21备份 2
分享
举报
fongms
fongms
·
2021-10-07
Like please
非常抱歉，此主贴已删除
看
1,510
回复
3
点赞
6
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3582495099582633","uuid":"3582495099582633","gmtCreate":1619402398685,"gmtModify":1624602600715,"name":"fongms","pinyin":"fongms","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":188,"tweetSize":21,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.57%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.71%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":692973818,"gmtCreate":1640835449206,"gmtModify":1640835449366,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692973818","repostId":"1100360696","repostType":4,"isVote":1,"tweetType":1,"viewCount":1015,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693375908,"gmtCreate":1639978751240,"gmtModify":1639978751354,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Tesla can buy for long term","listText":"Tesla can buy for long term","text":"Tesla can buy for long term","images":[{"img":"https://static.tigerbbs.com/1b84366b2a5685aed92cad7ddb219434","width":"1080","height":"2220"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693375908","isVote":1,"tweetType":1,"viewCount":1274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":603328778,"gmtCreate":1638368688641,"gmtModify":1638368688845,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Pfizer","listText":"Pfizer","text":"Pfizer","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603328778","repostId":"1119742422","repostType":4,"repost":{"id":"1119742422","kind":"news","pubTimestamp":1638368504,"share":"https://www.laohu8.com/m/news/1119742422?lang=&edition=full","pubTime":"2021-12-01 22:21","market":"us","language":"en","title":"Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?","url":"https://stock-news.laohu8.com/highlight/detail?id=1119742422","media":"TheStreet","summary":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks ","content":"<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p>\n<p>COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p>\n<p>The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p>\n<p>Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p>\n<p><b>Wall Street is neutral on Moderna</b></p>\n<p>Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p>\n<p>The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p>\n<p>Morgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p>\n<p><b>Pfizer: moderate buy, but experts are skeptical</b></p>\n<p>Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p>\n<p>JPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p>\n<p>The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p>\n<p><b>Wall Street Memes’ take</b></p>\n<p>COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p>\n<p>Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p>\n<p>Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna or Pfizer Stock: Which to Buy as Omicron Spreads? </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna or Pfizer Stock: Which to Buy as Omicron Spreads? \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 22:21 GMT+8 <a href=https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119742422","content_text":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.\nThe stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.\nFigure 1: SPY, MRNA and PFE performance in the past 5-trading days.\nBetween two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?\nWall Street is neutral on Moderna\nModerna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.\nThe most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.\nMorgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.\nPfizer: moderate buy, but experts are skeptical\nWall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.\nJPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.\nThe most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.\nWall Street Memes’ take\nCOVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.\nFigure 2: MRNA and PFE performance in the past 5-years.\nPfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.\nDue to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1086,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877648212,"gmtCreate":1637929743063,"gmtModify":1637929743124,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Its good","listText":"Its good","text":"Its good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877648212","repostId":"1145084508","repostType":4,"repost":{"id":"1145084508","kind":"news","pubTimestamp":1637929067,"share":"https://www.laohu8.com/m/news/1145084508?lang=&edition=full","pubTime":"2021-11-26 20:17","market":"us","language":"en","title":"Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=1145084508","media":"Barrons","summary":"Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at ","content":"<p>Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.</p>\n<p>Concerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.</p>\n<p>What we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.</p>\n<p>What we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.</p>\n<p>That’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.</p>\n<p>But we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.</p>\n<p>But for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFear, Not Calculated Trading, Is Behind Today’s Covid Market Crash\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 20:17 GMT+8 <a href=https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.\nConcerns around a new, heavily-mutated variant of...</p>\n\n<a href=\"https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1145084508","content_text":"Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.\nConcerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.\nWhat we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.\nWhat we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.\nThat’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.\nBut we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.\nBut for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":784,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875684296,"gmtCreate":1637643512247,"gmtModify":1637643512247,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Power","listText":"Power","text":"Power","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875684296","repostId":"2185808120","repostType":4,"repost":{"id":"2185808120","kind":"highlight","pubTimestamp":1637625517,"share":"https://www.laohu8.com/m/news/2185808120?lang=&edition=full","pubTime":"2021-11-23 07:58","market":"us","language":"en","title":"Here's what Powell's nomination for 2nd term as Fed chairman means for markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2185808120","media":"MarketWatch","summary":"Investors buoyed by 'continuity' as rival Brainard gets No. 2 spot, analysts say\nMarketWatch photo i","content":"<p>Investors buoyed by 'continuity' as rival Brainard gets No. 2 spot, analysts say</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/96d3ac1d26d057b0dd795501f245715c\" tg-width=\"700\" tg-height=\"487\" referrerpolicy=\"no-referrer\"><span>MarketWatch photo illustration/Getty Images</span></p>\n<p>Stock-market investors appeared to be cheering President Joe Biden's decision Monday to nominate Jerome Powell to serve a second four-year term as Federal Reserve chairman.</p>\n<p>The move had been widely anticipated by many, including betting markets.</p>\n<p>Some questions about Powell being renamed to the helm of the central had been lingering as markets have been anxious about a surge in inflation in the aftermath of the pandemic, and some have argued that the central bank needs to employ more aggressive tactics or risk a 1970s-style surge in the price of goods and services amid supply-chain bottlenecks and a surge in demand.</p>\n<p>Biden's choice was seen as coming down to Powell or Fed Gov. Lael Brainard, who was viewed by analysts as potentially more dovish on inflation. Biden nominated Brainard to a term as vice chairwoman, succeeding Richard Clarida, whose term as the central bank's No. 2 official expires on Jan. 31.</p>\n<p>\"Both were great candidates but sticking with Powell provided valuable continuity as the Fed seeks to implement its new framework and continue to put employment alongside price stability as a core mandate,\" said Kathryn Judge, a professor at Columbia Law School. \"Particularly with recent price increases and growing concerns about inflation, there are benefits from standing by a trusted and widely respected leader.\"</p>\n<p>The Dow Jones Industrial Average , the S&P 500 index and the Nasdaq Composite Index were all trading at or near records.</p>\n<p>\"The reappointment of Chairman Powell is a very positive development for markets and the economy because it provides continuity at a critical time,\" wrote Chris Zaccarelli, chief investment officer for Independent Advisor Alliance, in emailed comments.</p>\n<p>Powell's nomination also comes as the Fed has begun to taper its monthly purchases of Treasurys and mortgage-backed securities, on a timetable to wind down the program by June. Many also are anticipating that the Fed also might look to raise rates two or three times in 2022 as it attempts to rein in the surge in inflation and normalize interest rates in the aftermath of the worst pandemic in over a century.</p>\n<p>\"The economy is experiencing an increase in inflation and the Fed has already taken steps to reduce their extraordinary stimulus measures (tapering), but they will need to move more quickly in addressing the inflation threats so that they don't become entrenched,\" Zaccarelli writes.</p>\n<p>The nominations end months of uncertainty and speculation about the leadership of the Fed at what is viewed as a crucial time in the recovery phase of the economy. Markets have been climbing to all-time highs even as yields for long-dated Treasurys were receding, suggesting that doubts remain about the economic outlook.</p>\n<p>The yield for the 10-year Treasury note was hovering just below 1.60%, after climbing over 5 basis points, while the S&P 500 and the Nasdaq Composite indexes touched record intraday highs on Monday, the start of a historically solid period for equities in the week of Thanksgiving.</p>\n<p>On top of that, the Fed appears split about monetary-policy next steps, with some advocating for a go-slow approach to tapering and interest-rate raises, while others have been championing a faster rate of normalization moves to beat back inflation. The pace of consumer inflation over the past year marched to 6.2% in October from 5.4% in the prior month. That is more than triple the Federal Reserve's 2% target and is the highest rate since November 1990.</p>\n<p>The outlook for inflation seems uncertain, with some betting that pricing pressures will intensify, while others are making the case that inflation is in the process of peaking.</p>\n<p>For his part, Powell has been viewed by supporters within the administration as a steady hand, The Wall Street Journal reported, citing sources, describing him as helping \"restore bipartisan support for the central bank one decade after its reputation was badly bruised by the 2008 financial crisis.\"</p>\n<p>\"I have full confidence after their trial by fire over the last 20 months that Chair Powell and Dr. Brainard will provide the strong leadership our country needs,\" Biden said in a statement.</p>\n<p>The Senate is expected to confirm Powell, 68, before his first term expires in February.</p>\n<p>The Journal report said that putting Brainard as the Fed No. 2 represents a compromise for Biden with progressives in his party who had criticized Powell. Indeed, Democratic Sen. Elizabeth Warren of Massachusetts, accused Powell of watering down financial safeguards put in place after the panic of 2008 and called him a \"dangerous man.\"</p>\n<p>Ryan Detrick, chief market strategist for LPL Financial, Powell's renomination represents \"one less worry now,\" for markets participants.</p>\n<p>Jeff Klingelhofer, co-head of investments at Thornburg Investment Management, said that \"with elevating inflation concerns on just about everyone's mind, Brainard would have been more difficult for the market to digest as chair.\"</p>\n<p>\"Her appointment to vice chair offers Democrats a ballast to Powell and a likely regulatory win,\" he wrote, in emailed remarks.</p>\n<p>Biden will still oversee three other nominations for the Fed, including a replacement for Federal Reserve Gov. Randal Quarles, after a number of members announcement early retirements. Quarles said that he would resign at the end of December.</p>\n<p>Meanwhile, Powell's pick is likely to be a positive for digital assets like bitcoin , which the central banker has said that he would not move to restrict. The Fed also has been working on its own central bank digital currency, or CBDC.</p>\n<p>Bank stocks also were climbing reports, MarketWatch's Steve Gelsi. He notes that Brainard's name had come up as someone who might take bank regulator to replace the position being vacated by Trump nominee Quarles. The position could be vacated for some time, with potential candidates including Atlanta Fed President Raphael Bostic, former Fed Gov. Sarah Bloom Raskin and acting comptroller of the currency Michael Hsu in the mix.</p>\n<p>The financial sectors rose 1.4% on Monday, among the best performing among the S&P 500's 11 sectors on Monday. The SPDR S&P Bank ETF rose 1.3%, while the Invesco KBW Bank ETF rose 1.8%, as Treasury yields climbed on the session.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's what Powell's nomination for 2nd term as Fed chairman means for markets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's what Powell's nomination for 2nd term as Fed chairman means for markets\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-23 07:58 GMT+8 <a href=https://www.marketwatch.com/story/heres-what-powells-nomination-for-2nd-term-as-fed-chairman-means-for-markets-11637599539?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors buoyed by 'continuity' as rival Brainard gets No. 2 spot, analysts say\nMarketWatch photo illustration/Getty Images\nStock-market investors appeared to be cheering President Joe Biden's ...</p>\n\n<a href=\"https://www.marketwatch.com/story/heres-what-powells-nomination-for-2nd-term-as-fed-chairman-means-for-markets-11637599539?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/heres-what-powells-nomination-for-2nd-term-as-fed-chairman-means-for-markets-11637599539?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185808120","content_text":"Investors buoyed by 'continuity' as rival Brainard gets No. 2 spot, analysts say\nMarketWatch photo illustration/Getty Images\nStock-market investors appeared to be cheering President Joe Biden's decision Monday to nominate Jerome Powell to serve a second four-year term as Federal Reserve chairman.\nThe move had been widely anticipated by many, including betting markets.\nSome questions about Powell being renamed to the helm of the central had been lingering as markets have been anxious about a surge in inflation in the aftermath of the pandemic, and some have argued that the central bank needs to employ more aggressive tactics or risk a 1970s-style surge in the price of goods and services amid supply-chain bottlenecks and a surge in demand.\nBiden's choice was seen as coming down to Powell or Fed Gov. Lael Brainard, who was viewed by analysts as potentially more dovish on inflation. Biden nominated Brainard to a term as vice chairwoman, succeeding Richard Clarida, whose term as the central bank's No. 2 official expires on Jan. 31.\n\"Both were great candidates but sticking with Powell provided valuable continuity as the Fed seeks to implement its new framework and continue to put employment alongside price stability as a core mandate,\" said Kathryn Judge, a professor at Columbia Law School. \"Particularly with recent price increases and growing concerns about inflation, there are benefits from standing by a trusted and widely respected leader.\"\nThe Dow Jones Industrial Average , the S&P 500 index and the Nasdaq Composite Index were all trading at or near records.\n\"The reappointment of Chairman Powell is a very positive development for markets and the economy because it provides continuity at a critical time,\" wrote Chris Zaccarelli, chief investment officer for Independent Advisor Alliance, in emailed comments.\nPowell's nomination also comes as the Fed has begun to taper its monthly purchases of Treasurys and mortgage-backed securities, on a timetable to wind down the program by June. Many also are anticipating that the Fed also might look to raise rates two or three times in 2022 as it attempts to rein in the surge in inflation and normalize interest rates in the aftermath of the worst pandemic in over a century.\n\"The economy is experiencing an increase in inflation and the Fed has already taken steps to reduce their extraordinary stimulus measures (tapering), but they will need to move more quickly in addressing the inflation threats so that they don't become entrenched,\" Zaccarelli writes.\nThe nominations end months of uncertainty and speculation about the leadership of the Fed at what is viewed as a crucial time in the recovery phase of the economy. Markets have been climbing to all-time highs even as yields for long-dated Treasurys were receding, suggesting that doubts remain about the economic outlook.\nThe yield for the 10-year Treasury note was hovering just below 1.60%, after climbing over 5 basis points, while the S&P 500 and the Nasdaq Composite indexes touched record intraday highs on Monday, the start of a historically solid period for equities in the week of Thanksgiving.\nOn top of that, the Fed appears split about monetary-policy next steps, with some advocating for a go-slow approach to tapering and interest-rate raises, while others have been championing a faster rate of normalization moves to beat back inflation. The pace of consumer inflation over the past year marched to 6.2% in October from 5.4% in the prior month. That is more than triple the Federal Reserve's 2% target and is the highest rate since November 1990.\nThe outlook for inflation seems uncertain, with some betting that pricing pressures will intensify, while others are making the case that inflation is in the process of peaking.\nFor his part, Powell has been viewed by supporters within the administration as a steady hand, The Wall Street Journal reported, citing sources, describing him as helping \"restore bipartisan support for the central bank one decade after its reputation was badly bruised by the 2008 financial crisis.\"\n\"I have full confidence after their trial by fire over the last 20 months that Chair Powell and Dr. Brainard will provide the strong leadership our country needs,\" Biden said in a statement.\nThe Senate is expected to confirm Powell, 68, before his first term expires in February.\nThe Journal report said that putting Brainard as the Fed No. 2 represents a compromise for Biden with progressives in his party who had criticized Powell. Indeed, Democratic Sen. Elizabeth Warren of Massachusetts, accused Powell of watering down financial safeguards put in place after the panic of 2008 and called him a \"dangerous man.\"\nRyan Detrick, chief market strategist for LPL Financial, Powell's renomination represents \"one less worry now,\" for markets participants.\nJeff Klingelhofer, co-head of investments at Thornburg Investment Management, said that \"with elevating inflation concerns on just about everyone's mind, Brainard would have been more difficult for the market to digest as chair.\"\n\"Her appointment to vice chair offers Democrats a ballast to Powell and a likely regulatory win,\" he wrote, in emailed remarks.\nBiden will still oversee three other nominations for the Fed, including a replacement for Federal Reserve Gov. Randal Quarles, after a number of members announcement early retirements. Quarles said that he would resign at the end of December.\nMeanwhile, Powell's pick is likely to be a positive for digital assets like bitcoin , which the central banker has said that he would not move to restrict. The Fed also has been working on its own central bank digital currency, or CBDC.\nBank stocks also were climbing reports, MarketWatch's Steve Gelsi. He notes that Brainard's name had come up as someone who might take bank regulator to replace the position being vacated by Trump nominee Quarles. The position could be vacated for some time, with potential candidates including Atlanta Fed President Raphael Bostic, former Fed Gov. Sarah Bloom Raskin and acting comptroller of the currency Michael Hsu in the mix.\nThe financial sectors rose 1.4% on Monday, among the best performing among the S&P 500's 11 sectors on Monday. The SPDR S&P Bank ETF rose 1.3%, while the Invesco KBW Bank ETF rose 1.8%, as Treasury yields climbed on the session.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847705383,"gmtCreate":1636552134922,"gmtModify":1636552135082,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847705383","repostId":"1112315702","repostType":4,"repost":{"id":"1112315702","kind":"news","pubTimestamp":1636551867,"share":"https://www.laohu8.com/m/news/1112315702?lang=&edition=full","pubTime":"2021-11-10 21:44","market":"us","language":"en","title":"Why Are PubMatic Shares Trading Higher Premarket?","url":"https://stock-news.laohu8.com/highlight/detail?id=1112315702","media":"Benzinga","summary":"Oppenheimer analyst Jason Helfstein raised the price target on PubMatic Inc to $50 from $45, implyin","content":"<ul>\n <li><b>Oppenheimer</b> analyst Jason Helfstein raised the price target on <b>PubMatic Inc</b> to $50 from $45, implying a 55.7% upside, and reiterated an Outperform.</li>\n <li>The company's Q3 results and guidance suggest it is gaining share and has been able to turn <b>Apple Inc's</b> (NASDAQ: AAPL) Identifier for Advertisers and advertisers to focus on the removal of cookies into a tailwind.</li>\n <li>The analyst believes PubMatic is \"successfully moving closer to advertisers and agencies.\"</li>\n <li>PubMatic reported third-quarter FY21 revenue growth of 54% year-on-year to $58.1 million.</li>\n <li>\"This quarter marks our fourth consecutive quarter of organic revenue growth above 50% and adjusted EBITDA margin over 30%,\" CEO Rajeev Goel said.</li>\n <li>PubMatic processed 23.9 trillion impressions in Q3, a 103% increase Y/Y as publishers continued to expand their inventory on the PubMatic platform.</li>\n <li>Revenue from fast-growing advertising formats mobile and omnichannel video, which includes CTV, grew 64% Y/Y.</li>\n <li>Revenue from CTV grew by over seven times Y/Y. PubMatic programmatically monetized CTV inventory from 154 publishers, up from 114 publishers in Q2 of 2021.</li>\n <li><b>Outlook:</b> PubMatic sees Q4 revenue of $74 million - $76 million, above the consensus of $62.2 million.</li>\n <li>PubMatic raised FY21 revenue outlook to $225 million - $227 million (previously $205 million - $209 million), above the consensus of $208 million.</li>\n <li>PubMatic sees FY22 revenue of at least $281 million, above the consensus of $260.22 million.</li>\n <li><b>Price Action:</b>PUBM shares traded higher by 24.5% at $39.98 in the premarket session on the last check Wednesday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Are PubMatic Shares Trading Higher Premarket?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Are PubMatic Shares Trading Higher Premarket?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 21:44 GMT+8 <a href=https://www.benzinga.com/news/earnings/21/11/24007317/why-are-pubmatic-shares-trading-higher-premarket><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oppenheimer analyst Jason Helfstein raised the price target on PubMatic Inc to $50 from $45, implying a 55.7% upside, and reiterated an Outperform.\nThe company's Q3 results and guidance suggest it is ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/11/24007317/why-are-pubmatic-shares-trading-higher-premarket\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PUBM":"PubMatic, Inc."},"source_url":"https://www.benzinga.com/news/earnings/21/11/24007317/why-are-pubmatic-shares-trading-higher-premarket","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112315702","content_text":"Oppenheimer analyst Jason Helfstein raised the price target on PubMatic Inc to $50 from $45, implying a 55.7% upside, and reiterated an Outperform.\nThe company's Q3 results and guidance suggest it is gaining share and has been able to turn Apple Inc's (NASDAQ: AAPL) Identifier for Advertisers and advertisers to focus on the removal of cookies into a tailwind.\nThe analyst believes PubMatic is \"successfully moving closer to advertisers and agencies.\"\nPubMatic reported third-quarter FY21 revenue growth of 54% year-on-year to $58.1 million.\n\"This quarter marks our fourth consecutive quarter of organic revenue growth above 50% and adjusted EBITDA margin over 30%,\" CEO Rajeev Goel said.\nPubMatic processed 23.9 trillion impressions in Q3, a 103% increase Y/Y as publishers continued to expand their inventory on the PubMatic platform.\nRevenue from fast-growing advertising formats mobile and omnichannel video, which includes CTV, grew 64% Y/Y.\nRevenue from CTV grew by over seven times Y/Y. PubMatic programmatically monetized CTV inventory from 154 publishers, up from 114 publishers in Q2 of 2021.\nOutlook: PubMatic sees Q4 revenue of $74 million - $76 million, above the consensus of $62.2 million.\nPubMatic raised FY21 revenue outlook to $225 million - $227 million (previously $205 million - $209 million), above the consensus of $208 million.\nPubMatic sees FY22 revenue of at least $281 million, above the consensus of $260.22 million.\nPrice Action:PUBM shares traded higher by 24.5% at $39.98 in the premarket session on the last check Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856734075,"gmtCreate":1635212355063,"gmtModify":1635212355180,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856734075","repostId":"1184179575","repostType":2,"isVote":1,"tweetType":1,"viewCount":1363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821988958,"gmtCreate":1633686357602,"gmtModify":1633686357720,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Its a good start","listText":"Its a good start","text":"Its a good start","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821988958","repostId":"1108043623","repostType":4,"repost":{"id":"1108043623","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633682657,"share":"https://www.laohu8.com/m/news/1108043623?lang=&edition=full","pubTime":"2021-10-08 16:44","market":"us","language":"en","title":"Vaxart gained 7% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1108043623","media":"Tiger Newspress","summary":"(Oct 8) Vaxart, Inc shares are up 7% in premarket trading after publishing results in an animal mode","content":"<p>(Oct 8) <b><a href=\"https://laohu8.com/S/VXRT\">Vaxart, Inc</a></b> shares are up 7% in premarket trading after publishing results in an animal model that its COVID-19 vaccine pill can reduce airborne transmission of SARS-CoV-2.</p>\n<p>Hamsters were vaccinated orally or intranasally with the vaccine candidate and then exposed to high levels of the COVID-19 virus to promote vaccine breakthrough. Vaccinated hamsters cleared the virus in the nose and lungs quickly.</p>\n<p>But before clearing the infection, vaccinated hamsters were exposed to unvaccinated hamsters. The vaccinated hamsters infected fewer hamsters and created less severe clinical symptoms than did unvaccinated hamsters.</p>\n<p>Results were published in BioRxiv, and have yet to be peer-reviewed.</p>\n<p>Vaxart yesterday began recruitment in a phase 2 trial of the oral COVID vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/1ebf72c0d5d89ceb2daa800e4fd962dc\" tg-width=\"1176\" tg-height=\"569\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaxart gained 7% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaxart gained 7% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-08 16:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Oct 8) <b><a href=\"https://laohu8.com/S/VXRT\">Vaxart, Inc</a></b> shares are up 7% in premarket trading after publishing results in an animal model that its COVID-19 vaccine pill can reduce airborne transmission of SARS-CoV-2.</p>\n<p>Hamsters were vaccinated orally or intranasally with the vaccine candidate and then exposed to high levels of the COVID-19 virus to promote vaccine breakthrough. Vaccinated hamsters cleared the virus in the nose and lungs quickly.</p>\n<p>But before clearing the infection, vaccinated hamsters were exposed to unvaccinated hamsters. The vaccinated hamsters infected fewer hamsters and created less severe clinical symptoms than did unvaccinated hamsters.</p>\n<p>Results were published in BioRxiv, and have yet to be peer-reviewed.</p>\n<p>Vaxart yesterday began recruitment in a phase 2 trial of the oral COVID vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/1ebf72c0d5d89ceb2daa800e4fd962dc\" tg-width=\"1176\" tg-height=\"569\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VXRT":"Vaxart, Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108043623","content_text":"(Oct 8) Vaxart, Inc shares are up 7% in premarket trading after publishing results in an animal model that its COVID-19 vaccine pill can reduce airborne transmission of SARS-CoV-2.\nHamsters were vaccinated orally or intranasally with the vaccine candidate and then exposed to high levels of the COVID-19 virus to promote vaccine breakthrough. Vaccinated hamsters cleared the virus in the nose and lungs quickly.\nBut before clearing the infection, vaccinated hamsters were exposed to unvaccinated hamsters. The vaccinated hamsters infected fewer hamsters and created less severe clinical symptoms than did unvaccinated hamsters.\nResults were published in BioRxiv, and have yet to be peer-reviewed.\nVaxart yesterday began recruitment in a phase 2 trial of the oral COVID vaccine.","news_type":1},"isVote":1,"tweetType":1,"viewCount":714,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823045212,"gmtCreate":1633567751384,"gmtModify":1633567923249,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823045212","repostId":"2173794328","repostType":4,"isVote":1,"tweetType":1,"viewCount":1225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823046429,"gmtCreate":1633567652267,"gmtModify":1633567652395,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582495099582633","authorIdStr":"3582495099582633"},"themes":[],"htmlText":"Like please ","listText":"Like please ","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/823046429","repostId":"2173948202","repostType":4,"isVote":1,"tweetType":1,"viewCount":1510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}